Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Rodriguez

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
NDT Plus|May 19, 2015
Secondary hyperparathyroidism disease stabilization following calcimimetic therapyJoão Frazão, Mariano Rodriguez
Seminars in Dialysis|August 28, 2009
Parathyroid hormone, a uremic toxinMariano Rodriguez, Victor Lorenzo
Nutrients|December 6, 2018
Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD)Mariano Rodriguez, Escolastico Aguilera-Tejero
Cureus|October 1, 2024
A Fatal Case of Severe Leg Edema and Necrotic Ulcers in a 14-Year-Old BoyCamilo Mariano-Rodriguez, Mario Magana
Kidney International|November 7, 2012
Enhanced induction of Cyp24a1 by FGF23 but low serum 24,25-dihydroxyvitamin D in CKD: implications for therapyAdriana S Dusso, Mariano Rodriguez
Clinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic optionsJohn Cunningham, Francesco Locatelli, Mariano Rodriguez
Current Opinion in Nephrology and Hypertension|June 6, 2013
New insights in regulation of calcium homeostasisArnold Felsenfeld, Mariano Rodriguez, Burton Levine
Seminars in Nephrology|May 1, 2014
Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?Pieter Evenepoel, Mariano Rodriguez, Markus Ketteler
American Journal of Physiology. Renal Physiology|October 28, 2004
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidismMariano Rodriguez, Edward Nemeth, David Martin
Current Vascular Pharmacology|May 30, 2013
Therapeutic use of calcitriolMariano Rodriguez, Juan R Munoz-Castaneda, Yolanda Almaden
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
NDT Plus|May 19, 2015
Secondary hyperparathyroidism disease stabilization following calcimimetic therapyJoão Frazão, Mariano Rodriguez
Seminars in Dialysis|August 28, 2009
Parathyroid hormone, a uremic toxinMariano Rodriguez, Victor Lorenzo
Nutrients|December 6, 2018
Energy-Dense Diets and Mineral Metabolism in the Context of Chronic Kidney Disease⁻Metabolic Bone Disease (CKD-MBD)Mariano Rodriguez, Escolastico Aguilera-Tejero
Cureus|October 1, 2024
A Fatal Case of Severe Leg Edema and Necrotic Ulcers in a 14-Year-Old BoyCamilo Mariano-Rodriguez, Mario Magana
Kidney International|November 7, 2012
Enhanced induction of Cyp24a1 by FGF23 but low serum 24,25-dihydroxyvitamin D in CKD: implications for therapyAdriana S Dusso, Mariano Rodriguez
Clinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic optionsJohn Cunningham, Francesco Locatelli, Mariano Rodriguez
Current Opinion in Nephrology and Hypertension|June 6, 2013
New insights in regulation of calcium homeostasisArnold Felsenfeld, Mariano Rodriguez, Burton Levine
Seminars in Nephrology|May 1, 2014
Laboratory abnormalities in CKD-MBD: markers, predictors, or mediators of disease?Pieter Evenepoel, Mariano Rodriguez, Markus Ketteler
American Journal of Physiology. Renal Physiology|October 28, 2004
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidismMariano Rodriguez, Edward Nemeth, David Martin
Current Vascular Pharmacology|May 30, 2013
Therapeutic use of calcitriolMariano Rodriguez, Juan R Munoz-Castaneda, Yolanda Almaden
Pageof 10